New approaches for understanding mechanisms of drug resistance in schistosomes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Parasitology

• Publication date

  2013-04-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1017/S0031182013000231PMID 23552512PMCID PMC3775338
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin.

  2013cited by this paper
• Adult somatic stem cells in the human parasite, Schistosoma mansoni

  2013cited by this paper
• The development of RNA interference (RNAi) in gastrointestinal nematodes

  2012influential reference
• Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans

  2012cited by this paper
• Pharmacology and potential physiological significance of schistosome multidrug resistance transporters.

  2012influential reference
• Antimalarials in the treatment of schistosomiasis.

  2012cited by this paper
• Ups and downs of RNA interference in parasitic nematodes.

  2012cited by this paper
• The sensitivity of Schistosoma japonicum to praziquantel: a field evaluation in areas with low endemicity of China.

  2012cited by this paper
• P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.

  2012cited by this paper
• Germline Transgenesis and Insertional Mutagenesis in Schistosoma mansoni Mediated by Murine Leukemia Virus

  2012cited by this paper
• Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro.

  2012cited by this paper
• RNAi silencing of type V collagen in Schistosoma japonicum affects parasite morphology, spawning, and hatching

  2012cited by this paper
• Bioinformatics meets parasitology

  2012cited by this paper
• The inability of tapeworm Hymenolepis diminuta and fluke Dicrocoelium dendriticum to metabolize praziquantel.

  2012cited by this paper
• A Systematically Improved High Quality Genome and Transcriptome of the Human Blood Fluke Schistosoma mansoni

  2012cited by this paper
• Crystal structure of the multidrug transporter P-glycoprotein from C. elegans

  2012cited by this paper
• Susceptibility or resistance of praziquantel in human schistosomiasis: a review

  2012cited by this paper
• An amino acid substitution in Fasciola hepatica P-glycoprotein from triclabendazole-resistant and triclabendazole-susceptible populations.

  2012cited by this paper
• An antibiotic selection marker for schistosome transgenesis.

  2012cited by this paper
• Genetic manipulation of schistosomes – progress with integration competent vectors

  2011cited by this paper
• Human Schistosomiasis Resistance to Praziquantel in China: Should We Be Worried?

  2011cited by this paper
• Tegumental Phosphodiesterase SmNPP-5 Is a Virulence Factor for Schistosomes

  2011cited by this paper
• Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil.

  2011cited by this paper
• [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory].

  2011cited by this paper
• ABC transporters involved in drug resistance in human parasites.

  2011cited by this paper
• Genetic Knockdown and Pharmacological Inhibition of Parasite Multidrug Resistance Transporters Disrupts Egg Production in Schistosoma mansoni

  2011influential reference
• Schistosoma comparative genomics: integrating genome structure, parasite biology and anthelmintic discovery.

  2011cited by this paper
• An Atlas for Schistosoma mansoni Organs and Life-Cycle Stages Using Cell Type-Specific Markers and Confocal Microscopy

  2011cited by this paper
• Human U6 promoter drives stronger shRNA activity than its schistosome orthologue in Schistosoma mansoni and human fibrosarcoma cells

  2011cited by this paper
• Promises and challenges in developing RNAi as a research tool and therapy.

  2011cited by this paper
• Liver fluke isolates: a question of provenance.

  2011cited by this paper
• Opposing Roles of Voltage-Gated Ca2+ Channels in Neuronal Control of Regenerative Patterning

  2011cited by this paper
• Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel

  2011cited by this paper
• SLO-1-Channels of Parasitic Nematodes Reconstitute Locomotor Behaviour and Emodepside Sensitivity in Caenorhabditis elegans slo-1 Loss of Function Mutants

  2011cited by this paper
• Selective Toxicity of the Anthelmintic Emodepside Revealed by Heterologous Expression of Human KCNMA1 in Caenorhabditis elegans

  2011cited by this paper
• Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails.

  2011cited by this paper
• Paving the way for transgenic schistosomes

  2011cited by this paper
• The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity

  2011cited by this paper
• FMRFamide-Like Peptides (FLPs) Enhance Voltage-Gated Calcium Currents to Elicit Muscle Contraction in the Human Parasite Schistosoma mansoni

  2010cited by this paper
• Cell cultures for schistosomes - Chances of success or wishful thinking?

  2010cited by this paper
• A Novel High Throughput Assay for Anthelmintic Drug Screening and Resistance Diagnosis by Real-Time Monitoring of Parasite Motility

  2010cited by this paper
• Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel.

  2010cited by this paper
• Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel

  2010cited by this paper
• Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China

  2010cited by this paper
• Vector-based RNA interference of cathepsin B1 in Schistosoma mansoni

  2010cited by this paper
• Structural biology: Last of the multidrug transporters.

  2010cited by this paper
• Structural biology: Last of the multidrug transporters

  2010cited by this paper
• microRNAs: a role in drug resistance in parasitic nematodes?

  2010cited by this paper
• Parasites and poverty: the case of schistosomiasis.

  2010cited by this paper
• Use of fluorescent probes as a useful tool to identify resistant Schistosoma mansoni isolates to praziquantel

  2010cited by this paper
• RNA Interference in Schistosoma mansoni Schistosomula: Selectivity, Sensitivity and Operation for Larger-Scale Screening

  2010cited by this paper
• Towards an understanding of the mechanism of action of praziquantel.

  2009cited by this paper
• Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

  2009cited by this paper
• Schistosomiasis in Africa: An Emerging Tragedy in Our New Global Health Decade

  2009cited by this paper
• Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs

  2009cited by this paper
• A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni

  2009cited by this paper
• Chemotherapy and Drug Resistance in Schistosomiasis,Fascioliasis and Tapeworm Infections

  2009cited by this paper
• Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni

  2009cited by this paper
• A Novel Biological Activity of Praziquantel Requiring Voltage-Operated Ca2+ Channel β Subunits: Subversion of Flatworm Regenerative Polarity

  2009cited by this paper
• Genomic linkage map of the human blood fluke Schistosoma mansoni

  2009cited by this paper
• ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer

  2009cited by this paper
• Phenotypic Screen of Early-Developing Larvae of the Blood Fluke, Schistosoma mansoni, using RNA Interference

  2009cited by this paper
• Drug resistance mechanisms in helminths: is it survival of the fittest?

  2009cited by this paper
• Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility.

  2009cited by this paper
• RNA interference in schistosomes: machinery and methodology

  2009cited by this paper
• Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni.

  2009cited by this paper
• Echinococcus multilocularis as an experimental model in stem cell research and molecular host-parasite interaction

  2009cited by this paper
• P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus

  2009cited by this paper
• In vitro and in vivo evaluation of small interference RNA‐mediated gynaecophoral canal protein silencing in Schistosoma japonicum

  2009cited by this paper
• Advances in mRNA Silencing and Transgene Expression: a Gateway to Functional Genomics in Schistosomes

  2009cited by this paper
• Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths

  2009influential reference
• Response of Schistosoma mansoni Isolates Having Different Drug Sensitivity to Praziquantel Over Several Life Cycle Passages with and Without Therapeutic Pressure

  2008cited by this paper
• Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.

  2008cited by this paper
• Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death.

  2008cited by this paper
• Genuine functions of P-glycoprotein (ABCB1).

  2008cited by this paper
• Expression of ATP-binding cassette multidrug transporters in the giant liver fluke Fasciola gigantica and their possible involvement in the transport of bile salts and anthelmintics

  2008cited by this paper
• Schistosoma mansoni: evaluation of an RNAi-based treatment targeting HGPRTase gene.

  2008cited by this paper
• Identification of oxadiazoles as new drug leads for the control of schistosomiasis

  2008cited by this paper
• Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

  2008cited by this paper
• Routine Kato-Katz technique underestimates the prevalence of Schistosoma japonicum: a case study in an endemic area of the People's Republic of China.

  2008cited by this paper
• Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts

  2008cited by this paper
• Molecular analysis of stem cells and their descendants during cell turnover and regeneration in the planarian Schmidtea mediterranea.

  2008cited by this paper
• Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.

  2007cited by this paper
• Cytochalasin D abolishes the schistosomicidal activity of praziquantel.

  2007cited by this paper
• Multiple molecular mechanisms for multidrug resistance transporters

  2007cited by this paper
• The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux.

  2006cited by this paper
• Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance

  2006influential reference
• Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection.

  2006cited by this paper
• The effects of drugs, ions, and poly-l-lysine on the excretory system of Schistosoma mansoni.

  2006cited by this paper
• Targeting multidrug resistance in cancer

  2006influential reference
• Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992-2001).

  2005cited by this paper
• Current and Future Antischistosomal Drugs

  2005cited by this paper
• Similarities between ATP-dependent and ion-coupled multidrug transporters.

  2005cited by this paper
• Are Ca2+ channels targets of praziquantel action?

  2005cited by this paper
• Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.

  2005cited by this paper
• Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa.

  2005cited by this paper
• Responses of the surface membrane and excretory system of Schistosoma mansoni to damage and to treatment with praziquantel and other biomolecules

  2005cited by this paper
• Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni.

  2005cited by this paper
• Neglected tropical diseases

  2005cited by this paper
• Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.

  2005cited by this paper

• Zoonotic Schistosomiasis: The Crossroads Between Animal and Human Schistosomiasis in Africa: Narrative Review

  2025cites this paper
• Abundant genetic variation is retained in many laboratory schistosome populations

  2025cites this paper
• Praziquantel resistance in schistosomes: a brief report

  2024cites this paper
• Insights into the epidemiology, pathogenesis, and differential diagnosis of schistosomiasis

  2024cites this paper
• Sanguinarine: an alkaloid with promising in vitro and in vivo antiparasitic activity against different developmental stages of Schistosoma mansoni and in silico pharmacokinetic properties (ADMET)

  2024cites this paper
• Abundant genetic variation is retained in many laboratory schistosome populations

  2024cites this paper
• Single-Dose Drug Development Candidate for Schistosomiasis.

  2024cites this paper
• Rhodopsin orphan GPCR20 interacts with neuropeptides and directs growth, sexual differentiation, and egg production in female Schistosoma mansoni

  2023cites this paper
• Antigens of Three Medically Important Schistosoma spp

  2022cites this paper
• A review of the genetic determinants of praziquantel resistance in Schistosoma mansoni: Is praziquantel and intestinal schistosomiasis a perfect match?

  2022cites this paper
• Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel

  2022cites this paper
• Schistosome TRPML channels play a role in neuromuscular activity and tegumental integrity.

  2022cites this paper
• Hypoxanthine guanine phosphoribosyl transferases SmHGPRTases functional roles in Schistosoma mansoni

  2022cites this paper
• Neolignans isolated from Saururus cernuus L. (Saururaceae) exhibit efficacy against Schistosoma mansoni

  2022cites this paper
• Prevention and Eradication of Biofilm by Dendrimers: A Possibility Still Little Explored

  2022cites this paper
• Prospects for genomic surveillance for selection in schistosome parasites

  2022cites this paper
• Prevention and Eradication of Biofilm by Dendrimers: A Possibility Still Little Explored

  2022cites this paper
• Parasitic helminth infections in humans modulate Trefoil Factor levels in a manner dependent on the species of parasite and age of the host

  2021cites this paper
• Mitochondrial genome of Bulinus truncatus (Gastropoda: Lymnaeoidea): Implications for snail systematics and schistosome epidemiology

  2021cites this paper
• MULTIDRUG RESISTANCE: OVERVIEW

  2021cites this paper
• The Schistosoma mansoni nuclear receptor FTZ-F1 maintains esophageal gland function via transcriptional regulation of meg-8.3

  2021cites this paper
• Mechanisms of Anti-protozoan/Helminth Drug Resistance

  2021cites this paper
• A kaempferol derivative isolated from Lysimachia ramosa (Wall ex. Duby) induced alteration of acetyl cholinesterase and nitric oxide synthase in Raillietina echinobothrida.

  2021cites this paper
• UROGENITAL SCHISTOSOMIASIS AMONG PRIMARY SCHOOL PUPILS IN AMAGUNZE, ENUGU STATE, SOUTHEAST NIGERIA

  2021cites this paper
• Long non-coding RNA levels can be modulated by 5-azacytidine in Schistosoma mansoni

  2020cites this paper
• Effect of Praziquantel on Schistosoma mekongi Proteome and Phosphoproteome

  2020cites this paper
• Schistosome TRP channels: An appraisal

  2020cites this paper
• Genetic architecture of transmission stage production and virulence in schistosome parasites

  2020cites this paper
• Proteomic and deep sequencing analysis of extracellular vesicles isolated from adult male and female Schistosoma japonicum

  2020cites this paper
• The impact of cinnarizine and griseofulvin on juvenile and adult stages of Schistosoma mansoni.

  2019cites this paper
• Structural basis for the design of selective inhibitors for Schistosoma mansoni dihydroorotate dehydrogenase.

  2019cites this paper
• The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel

  2019cites this paper
• The Journey to Discovering a Flatworm Target of Praziquantel: A Long TRP.

  2019cites this paper
• Host miR-148 regulates a macrophage-mediated immune response during Schistosoma japonicum infection.

  2019cites this paper
• Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier

  2019cites this paper
• In vitro activity of usnic acid potassium salt against different developmental stages of Schistosoma mansoni: An ultrastructural study.

  2019cites this paper
• The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel

  2019cites this paper
• WIPO Re:Search—A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis

  2019influential citation
• Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal Agents.

  2018cites this paper
• Atypical pharmacology of schistosome TRPA1-like ion channels

  2018cites this paper
• Genetic Crosses and Linkage Mapping in Schistosome Parasites.

  2018cites this paper
• TRP channels as potential targets for antischistosomals

  2018cites this paper
• The mechanism of action of praziquantel: can new drugs exploit similar mechanisms?

  2018cites this paper
• Molecular Application of Aptamers in the Diagnosis and Treatment of Cancer and Communicable Diseases

  2018cites this paper
• Phytochemical Molluscicides and Schistosomiasis: What We Know and What We Still Need to Learn.

  2018cites this paper
• In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets

  2018cites this paper
• Changes in Liver Cell Apoptosis after Vaccination by Schistosomulae Antigen and/or Artesunat Treatment in Murine Schistosoma Mansoni

  2018cites this paper
• Phytochemical Molluscicides and Schistosomiasis: What We Know and What We Still Need to Learn

  2018cites this paper
• Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni

  2017cites this paper
• Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy

  2017cites this paper
• Differential distribution and biochemical characteristics of hydrolases among developmental stages of Schistosoma mansoni may offer new anti-parasite targets.

  2017cites this paper
• Pharmacological and pharmacokinetic studies on trematocidal drugs : praziquantel and two synthetic peroxide lead candidates

  2017cites this paper
• Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials.

  2017cites this paper
• Chemotherapy and Drug Resistance in Schistosomiasis and Other Trematode and Cestode Infections

  2017cites this paper
• A high-throughput colorimetric assay for detection of Schistosoma mansoni viability based on the tetrazolium salt XTT

  2017cites this paper
• The self‐curing phenomenon of schistosome infection in rhesus macaques: insight from in vitro studies

  2017cites this paper
• Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni: A novel insight.

  2017cites this paper
• Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance

  2017cites this paper
• The effects of subcurative praziquantel treatment on life‐history traits and trade‐offs in drug‐resistant Schistosoma mansoni

  2017influential citation
• Polymorphism in ABC transporter genes of Dirofilaria immitis

  2017cites this paper
• (Epi)genetic Inheritance in Schistosoma mansoni: A Systems Approach

  2017cites this paper
• Receptor Antagonist of IL‐13 Exerts a Potential Negative Regulation During Early Infection of Human Schistosomiasis

  2016cites this paper
• TRP channels in schistosomes

  2016cites this paper
• Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.

  2016cites this paper
• Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems

  2016cites this paper
• Bimodal X‐ray and Infrared Imaging of an Organometallic Derivative of Praziquantel in Schistosoma mansoni

  2016cites this paper
• Genetic Variations In Schistosoma Haematobium And Disease Severity In The Greater Accra Region

  2016cites this paper
• A Miniaturized Screen of a Schistosoma mansoni Serotonergic G Protein-Coupled Receptor Identifies Novel Classes of Parasite-Selective Inhibitors

  2016cites this paper
• Evaluation of Echinostoma liei worm, metacercaria and redia antigens for schistosomiasis control.

  2015cites this paper
• Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms

  2015cites this paper
• Defining the Schistosoma haematobium kinome enables the prediction of essential kinases as anti-schistosome drug targets

  2015cites this paper
• Structure–function analysis of apical membrane‐associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control

  2015cites this paper
• Praziquantel and Arachidonic Acid Combination — An Innovative Approach to the Treatment of Schistosomiasis

  2015cites this paper
• Contribution de l’épigénétique dans les Dauermodifikations et l’évolution adaptative chez le parasite humain Schistosoma mansoni et le corail tropical Pocillopora damicornis

  2015influential citation
• Modelling the effects of mass drug administration on the molecular epidemiology of schistosomes.

  2015cites this paper
• Genome mining offers a new starting point for parasitology research

  2015cites this paper
• Evidence for Novel Pharmacological Sensitivities of Transient Receptor Potential (TRP) Channels in Schistosoma mansoni

  2015cites this paper
• Efficacy and Safety of Arachidonic Acid for Treatment of School-Age Children in Schistosoma mansoni High-Endemicity Regions

  2015cites this paper
• Drug-Induced Exposure of Schistosoma mansoni Antigens SmCD59a and SmKK7

  2015cites this paper
• Praziquantel in a Clay Nanoformulation Shows More Bioavailability and Higher Efficacy against Murine Schistosoma mansoni Infection

  2015cites this paper
• Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas

  2015influential citation
• Ergot Alkaloids (Re)generate New Leads as Antiparasitics

  2015cites this paper
• Exploring molecular variation in Schistosoma japonicum in China

  2015cites this paper
• Toward organometallic antischistosomal drug candidates.

  2015cites this paper
• Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis.

  2015cites this paper
• Multidrug Resistance: An Emerging Crisis

  2014cites this paper
• Exposure to hycanthone alters chromatin structure around specific gene functions and specific repeats in Schistosoma mansoni

  2014cites this paper
• Ion Channels and Drug Transporters as Targets for Anthelmintics

  2014cites this paper
• ESQUISTOSSOMOSE MANSÔNICA HUMANA: AVALIAÇÃO DO RECEPTOR ANTAGONISTA DE IL-13 (IL-13Rα2) E DA RESPOSTA IMUNE CELULAR

  2014cites this paper
• The challenge of antiparasitic resistance.

  2014cites this paper
• Inhibition or Knockdown of ABC Transporters Enhances Susceptibility of Adult and Juvenile Schistosomes to Praziquantel

  2014cites this paper
• Schistosome ABC multidrug transporters: From pharmacology to physiology

  2014cites this paper
• Crystal Structure of Schistosoma mansoni Arginase, a Potential Drug Target for the Treatment of Schistosomiasis

  2014cites this paper
• Preventive chemotherapy for schistosomiasis andsoil-transmitted helminthiasis by cotreatment withpraziquantel and albendazole

  2014cites this paper
• Apoptosis in schistosomes: toward novel targets for the treatment of schistosomiasis.

  2014cites this paper
• Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum

  2013cites this paper
• In vitro metabolic profile and in vivo antischistosomal activity studies of (η(6)-praziquantel)Cr(CO)3 derivatives.

  2013cites this paper
• A conventional polymerase chain reaction-based method for the diagnosis of human schistosomiasis in stool samples from individuals in a low-endemicity area

  2013cites this paper
• Genetic and genomic approaches to understanding drug resistance in parasites

  2013cites this paper
• Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites

  2013cites this paper